A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma

Clinical trial NCT06629597 · RECRUITING

Trial details

NCT number: NCT06629597
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma

Start date: 2024-12-31
Primary completion: 2027-12-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.